Preferred Label : aminosalicylic acid;
MeSH definition : An antitubercular agent often administered in association with ISONIAZID. The sodium
salt of the drug is better tolerated than the free acid.;
MeSH synonym : para-aminosalicylic acid; p aminosalicylic acid; Acid, Aminosalicylic; p-Aminosalicylic Acid; para aminosalicylic acid; 4-aminosalicylic acid; 4 aminosalicylic acid;
CISMeF synonym : pas;
MeSH hyponym : p-Aminosalicylic acid monolithium salt; p-Aminosalicylic Acid Monosodium Salt; Alumino-4-Aminosalicylic acid; p-Aminosalicylic Acid, Calcium (2:1) Salt; pamisyl; rezipas; p-Aminosalicylic acid, aluminum (2:1) salt; p-Aminosalicylic Acid, Monosodium Salt, Dihydrate; p-Aminosalicylic Acid Monopotassium Salt; p Aminosalicylic Acid Monolithium Salt; p Aminosalicylic Acid Monopotassium Salt; Alumino 4 Aminosalicylic Acid; p Aminosalicylic Acid Monosodium Salt;
MeSH CAS label : benzoic acid, 4-amino-2-hydroxy-;
MeSH Related Number : p-Aminosalicylic acid, calcium (2:1) salt; p-Aminosalicylic acid, monosodium salt, dihydrate; p-Aminosalicylic acid monosodium salt; p-Aminosalicylic acid monolithium salt; p-Aminosalicylic acid monopotassium salt; p-Aminosalicylic acid, aluminum (2:1) salt; 133-10-8 (p-Aminosalicylic acid monosodium salt); 65-49-6 (Aminosalicylic acid); 133-09-5; 133-15-3; 6018-19-5; 61891-33-6; 64240-79-5; S38B9W6AXW;
Registry Number MeSH : 65-49-6;
Related CAS MeSH : 64240-79-5 (p-Aminosalicylic acid monolithium salt); 133-09-5 (p-Aminosalicylic acid monopotassium salt); 61891-33-6 (p-Aminosalicylic acid, aluminum (2:1) salt); 133-15-3 (p-Aminosalicylic acid, calcium (2:1) salt); 6018-19-5 (p-Aminosalicylic acid, monosodium salt, dihydrate); S38B9W6AXW (p-Aminosalicylic acid monosodium salt);
MeSH annotation : AMINOSALICYLIC ACIDS is also available;
Wikipedia link : https://en.wikipedia.org/wiki/Aminosalicylic acid;
Codes EINECS : 200-613-5;
Is substance : O;
medicament (CISMeF) : O;
UNII : 5B2658E0N2;
InChIKey : WUBBRNOQWQTFEX-UHFFFAOYSA-N;
Origin ID : D010131;
UMLS CUI : C0030125;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
False automatic mappings
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- vadrine [MeSH Supplementary Concept]
Related MeSH term(s)
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
An antitubercular agent often administered in association with ISONIAZID. The sodium
salt of the drug is better tolerated than the free acid.
https://www.ema.europa.eu/medicines/human/EPAR/granupas-previously-para-aminosalicylic-acid-lucane
2016
false
United Kingdom
English
French
aminosalicylic acid
aminosalicylic acid
drug approval
europe
treatment outcome
aminosalicylic acid
adult
child
infant
adolescent
drug therapy, combination
tuberculosis, multidrug-resistant
antitubercular agents
antitubercular agents
drug interactions
mycobacterium tuberculosis
orphan drug production
summary of product characteristics
package leaflet
drug evaluation
syndication feed
pregnancy
breast feeding
Product containing para-aminosalicylic acid (medicinal product)
administration, oral
antibiotic therapy
---
http://www.has-sante.fr/portail/jcms/c_2572475/fr/quadrasa
http://www.has-sante.fr/portail/jcms/c_1003605/quadrasa
2015
false
France
French
p-Aminosalicylic Acid, Monosodium Salt, Dihydrate
aminosalicylic acid
administration, rectal
insurance, health, reimbursement
aminosalicylic acid and similar agents
colitis, ulcerative
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1782523/fr/granupas
2014
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
aminosalicylic acid
aminosalicylic acid
antitubercular agents
antitubercular agents
administration, oral
treatment outcome
aminosalicylic acid
drug therapy, combination
tuberculosis, multidrug-resistant
adult
child
infant
adolescent
antibiotic therapy
---
http://www.lecrat.eu/?s=P-aminosalicylate+de+sodium+%3D+PAS
France
French
antibiotic therapy
aminosalicylic acid
antitubercular agents
pregnancy
administration, oral
drug information
---